The metagenomics industry is witnessing rapid advancements driven by enhanced sequencing technologies and expanding applications in healthcare, agriculture, and environmental monitoring. Increasing adoption of high-throughput sequencing platforms coupled with growing demand for microbial diversity analysis is reshaping the market dynamics, highlighting substantial business growth potential for market companies globally.

The metagenomics market is estimated to be valued at USD 2.36 Bn in 2025 and is expected to reach USD 4.13 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.3% from 2025 to 2032.

This Metagenomics Market Trends is propelled by increasing investment in genomics research and rising integration of bioinformatics tools. The market report underscores expanded scope for customization and automation, bolstering precise microbial profiling across various sectors.

Market Segments
The metagenomics market can be segmented into sequencing type, application, and end-user categories.
- Sequencing Type: Includes shotgun sequencing, amplicon sequencing, and other approaches. Shotgun sequencing remains the dominant sub-segment owing to its comprehensive data output and has seen accelerated adoption due to its ability to generate vast metagenomics revenue, especially in the clinical research domain. Amplicon sequencing is the fastest-growing sub-segment, with extensive use in environmental microbiome studies reported in 2024.
- Application: Divided into clinical diagnostics, agriculture, environmental monitoring, and others. Clinical diagnostics dominates, driven by the rising prevalence of microbiome-related disease research. Environmental monitoring is the fastest-growing area, with government regulations and sustainability goals amplifying demand for soil and water microbial profiling in 2025.
- End User: Categories include pharmaceutical and biotechnology companies, research institutes, and contract research organizations (CROs). Pharmaceutical and biotechnology companies lead the segment due to greater funding and pipeline activities, whereas CROs are expanding rapidly as outsourcing trends gain momentum.

Market Driver
A significant market driver includes the increasing focus on personalized medicine and microbiome-based therapeutics. For instance, in 2024, over 60% of new R&D projects within leading pharma companies incorporated metagenomics data to tailor drug discovery processes. Regulatory support for next-generation sequencing (NGS) applications and enhanced data processing capabilities contributed to this trend, underpinning promising market revenue growth and reflecting the metagenomics market’s evolving landscape.

Segment Analysis: Sequencing Type
Focusing on sequencing type, shotgun sequencing accounted for the highest revenue in 2024 due to its ability to provide detailed functional insights across microbial communities, essential for clinical and agricultural use cases. Shotgun sequencing platforms enabled pharmaceutical companies to identify novel biomarkers more efficiently, aligning with rising demand for comprehensive microbial profiling. Amplicon sequencing, however, demonstrated the fastest CAGR within the segment, driven by cost-effectiveness and simplicity, expanding its footprint particularly in environmental and agricultural studies.

Consumer Behaviour Insights
Recent consumer behavior trends highlight a growing preference for customizable metagenomics solutions tailored to specific research needs, as evidenced by a 2025 survey indicating that 45% of end-users prioritized flexible sequencing protocols. Additionally, sustainability concerns are guiding buyers toward platforms and reagents with reduced environmental impact. A notable shift in digital consumption patterns reflected accelerated adoption of cloud-based data analytics for metagenomics, streamlining data processing and influencing purchasing decisions.

Key Players
Significant market players include Bio-Rad Laboratories, Inc., Illumina, Inc., PerkinElmer, Thermo Fisher Scientific, QIAGEN, Pacific Biosciences, Oxford Nanopore Technologies, Agilent Technologies, Novogene Corporation, BGI Group, F. Hoffmann-La Roche Ltd, and Illumina. In 2024, Illumina launched new high-throughput sequencing kits optimized for metagenomics applications, resulting in a 15% revenue growth in the first two quarters. Bio-Rad expanded regional operations in Asia-Pacific to cater to increasing demand. PerkinElmer enhanced its service portfolio with integrated bioinformatics solutions in 2025, improving client retention and market penetration.

Key Winning Strategies Adopted by Key Players
One impactful strategy was the strategic partnership between Bio-Rad Laboratories and leading research consortiums in 2025 to develop real-time metagenomics data platforms, significantly reducing processing time and driving broader adoption. Illumina’s focused investment in AI-driven data analytics platforms in 2024 enhanced the precision and scalability of metagenomics workflows, resulting in a measurable boost in product differentiation. Additionally, PerkinElmer’s deployment of eco-friendly sequencing reagents demonstrated commitment to sustainability, attracting a new segment of environmentally conscious consumers and positively impacting business growth.

FAQs

1. Who are the dominant players in the metagenomics market?
Dominant players include Bio-Rad Laboratories, Illumina, and PerkinElmer, who lead through product innovation, capacity expansion, and strategic partnerships to enhance their market presence.

2. What will be the size of the metagenomics market in the coming years?
The metagenomics market size is projected to grow from USD 2.36 billion in 2025 to USD 4.13 billion by 2032, with a CAGR of 8.3%, driven by rising applications across healthcare, agriculture, and environmental monitoring.

3. Which end-user industry has the largest growth opportunity?
The pharmaceutical and biotechnology sector holds the largest growth opportunity due to increased R&D investments focusing on personalized medicine and microbiome-based therapeutic solutions.

4. How will market development trends evolve over the next five years?
Market trends indicate accelerated adoption of AI-driven analytics, sustainable sequencing technologies, and expanded applications in agriculture and environmental sectors, fostering market growth and new revenue streams.

5. What is the nature of the competitive landscape and challenges in the metagenomics market?
The competitive landscape is marked by technological innovation and consolidation. Challenges include integration of complex data analytics and high operational costs, which players address through targeted R&D and strategic collaborations.

6. What go-to-market strategies are commonly adopted in the metagenomics market?
Common strategies include launching integrated bioinformatics solutions, forming strategic partnerships for platform development, and expanding regionally to tap emerging markets while emphasizing sustainability.

Get More Insights On- Metagenomics Market

Get this Report in Japanese Language: メタゲノミクス市場

Get this Report in Korean Language: 메타게놈학 시장

Read More Articles Related to this Industry

The Future of UV Lamp Technology: Innovations and Emerging Applications

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)